Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 07:50PM GMT
Release Date Price: $64.91 (+1.36%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Good afternoon, and welcome to the Barclays Virtual Health Care Conference. This is Jack Meehan from the Life Science Tools and Diagnostics team here at Barclays. And pleased to be hosting now Exact Sciences, joined by Chairman and CEO, Kevin Conroy; CFO, Jeff Elliott; and Head of Investor Relations, Megan Jones. Thanks again for joining us in the new format.

Kevin, would you like to kick it off with some introductory comments?

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Yes. Thanks, Jack, and welcome, everybody. It's great to be on the call and in certainly interesting times. I'd like to first lay out a high level of strategic overview of where Exact Sciences plans to go to innovate and bring new cancer tests to patients. We're focusing across multiple different cancer types and the range of early cancer detection and diagnosis all the way through answering the questions about guiding treatment, the appropriate treatment,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot